Another study suggests that MAL methylation could also be used as a biomarker in nasopharyngeal carcinomas [165], which is a tumor associated with Epstein–Barr virus, and in epithelial ovarian cancers positive for high-risk human papillomavirus [166]. Here, MAL is linked to ovarian carcinoma.